Nephrotic Syndrome News and Research

RSS
Nephrotic syndrome is characterized by a set of signs and symptoms including proteinuria, low protein levels in the blood, hypercholesterolemia, hypertriglyceridemia, and edema. It may be caused by various disorders of the kidney, and the management of the condition varies according to the specific case and the cause of the symptoms.
Rituximab alters T-cell metabolism in patients with nephrotic syndrome

Rituximab alters T-cell metabolism in patients with nephrotic syndrome

Early treatment helps patient recover from rare kidney disorder

Early treatment helps patient recover from rare kidney disorder

Rituximab shows remarkable success in adults with relapsing nephrotic syndrome

Rituximab shows remarkable success in adults with relapsing nephrotic syndrome

Suppression of cdc42 activity could be a promising therapy for nephrotic syndrome

Suppression of cdc42 activity could be a promising therapy for nephrotic syndrome

New autoimmune target identified in pediatric idiopathic nephrotic syndrome

New autoimmune target identified in pediatric idiopathic nephrotic syndrome

Autoantibodies against vinculin linked to childhood kidney disease

Autoantibodies against vinculin linked to childhood kidney disease

CDC report reveals COPD as the sixth leading cause of death in the U.S.

CDC report reveals COPD as the sixth leading cause of death in the U.S.

Hybrid technique identifies anti-nephrin autoantibodies as biomarker for kidney disorders with nephrotic syndrome

Hybrid technique identifies anti-nephrin autoantibodies as biomarker for kidney disorders with nephrotic syndrome

New cellular atlas of the kidney sheds light on disease

New cellular atlas of the kidney sheds light on disease

New treatment pathway identified for patients with idiopathic nephrotic syndrome

New treatment pathway identified for patients with idiopathic nephrotic syndrome

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

New chemical probe can selectively inhibit human COQ8A protein in cells

New chemical probe can selectively inhibit human COQ8A protein in cells

25 years on, varicella vaccination reports impressive success in the USA

25 years on, varicella vaccination reports impressive success in the USA

Quality improvement program enhances Pneumococcal vaccination rates amongst high risk patients

Quality improvement program enhances Pneumococcal vaccination rates amongst high risk patients

New DNA repair vehicle used to fix a common genetic cause of hereditary kidney disease

New DNA repair vehicle used to fix a common genetic cause of hereditary kidney disease

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Results of high-impact clinical trials could affect kidney-related medical care

Results of high-impact clinical trials could affect kidney-related medical care

Mild electrical stimulation with heat shock exerts protective effect against nephrotic syndrome

Mild electrical stimulation with heat shock exerts protective effect against nephrotic syndrome

High-impact clinical trial results could improve kidney-related medical care

High-impact clinical trial results could improve kidney-related medical care

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.